Autoantibodies specific for idiopathic inflammatory myopathy (myositis-specific
autoantibodies (MSAs)) are clinically useful biomarkers to help the diagnosis of …

Anti-synthetase syndrome (ASSD) is an autoimmune disease characterized by the presence
of autoantibodies targeting one of several aminoacyl t-RNA synthetases (aaRSs) along with …

Objective To identify similarities and differences in the clinical features of adult Japanese
patients with individual anti-aminoacyl-tRNA synthetase antibodies (anti-ARS Abs). Methods …

Objective. The aim was to study the prevalence, rate of appearance and severity of clinical
features in patients with different anti-synthetase syndrome (ASyS) autoantibodies. Methods …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications associated
with connective tissue diseases (CTDs), resulting in significant morbidity and mortality …

Polymyositis and dermatomyositis are inflammatory myopathies that differ in their clinical
features, histopathology, response to treatment, and prognosis. Although their clinical …

Autoantibodies are a hallmark in the diagnosis of many systemic autoimmune rheumatic
diseases (SARD) including idiopathic inflammatory myopathies (IIM). Based on their …

In patients with myositis, the lung is commonly involved, and the presence of anti-aminoacyl-
tRNA synthetase (anti-ARS) antibodies marks the presence or predicts the development of …

Objective To compare the cumulative survival and event free survival in patients with Jo-1
versus non-Jo-1 anti-tRNA synthetase autoantibodies (anti-synAb). Methods Anti-synAb …

The clinical phenotype and evolution of antisynthetase syndrome (ASS) are heterogeneous.
This study was therefore undertaken to identify subgroups of ASS patients with similar …